Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel S Merseburger

Showing results (301-310 of 323) with videos related to

Pageof 33
Sort By:
The New England Journal of Medicine|June 1, 2019
Apalutamide for Metastatic, Castration-Sensitive Prostate CancerKim N Chi, Neeraj Agarwal, Anders Bjartell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2021
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN StudyKim N Chi, Simon Chowdhury, Anders Bjartell, et al.
European Urology Focus|June 5, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract CarcinomaCora N Sternberg, Yohann Loriot, Ernest Choy, et al.
World Journal of Urology|April 3, 2014
Is there an anti-androgen withdrawal syndrome for enzalutamide?Christoph A J von Klot, Mario W Kramer, Alena Böker, et al.
European Urology|June 26, 2012
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomyShahrokh F Shariat, Michael Rink, Behfar Ehdaie, et al.
World Journal of Urology|March 14, 2024
Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert networkAxel S Merseburger, Ganesh Bakshi, Dong-Yi Chen, et al.
Nature Communications|May 27, 2024
Proteomic analysis of the urothelial cancer landscapeFranz F Dressler, Falk Diedrichs, Deema Sabtan, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
International Urology and Nephrology|June 2, 2026
Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysisCaio Vinicius Suartz, Mateus Silva Santos Costa, Caio Felipe Araujo Matalani, et al.
World Journal of Urology|July 27, 2012
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?Michael Rink, Shahrokh F Shariat, Evanguelos Xylinas, et al.
Pageof 33

Showing results (301-310 of 323) with videos related to

Sort By:
Pageof 33
The New England Journal of Medicine|June 1, 2019
Apalutamide for Metastatic, Castration-Sensitive Prostate CancerKim N Chi, Neeraj Agarwal, Anders Bjartell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2021
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN StudyKim N Chi, Simon Chowdhury, Anders Bjartell, et al.
European Urology Focus|June 5, 2024
Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract CarcinomaCora N Sternberg, Yohann Loriot, Ernest Choy, et al.
World Journal of Urology|April 3, 2014
Is there an anti-androgen withdrawal syndrome for enzalutamide?Christoph A J von Klot, Mario W Kramer, Alena Böker, et al.
European Urology|June 26, 2012
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomyShahrokh F Shariat, Michael Rink, Behfar Ehdaie, et al.
World Journal of Urology|March 14, 2024
Cardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert networkAxel S Merseburger, Ganesh Bakshi, Dong-Yi Chen, et al.
Nature Communications|May 27, 2024
Proteomic analysis of the urothelial cancer landscapeFranz F Dressler, Falk Diedrichs, Deema Sabtan, et al.
European Urology|April 25, 2022
Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysisPawel Rajwa, Benjamin Pradere, Giorgio Gandaglia, et al.
International Urology and Nephrology|June 2, 2026
Comparative functional, perioperative and oncological outcomes of robot-assisted and open radical prostatectomy: a systematic review and meta-analysisCaio Vinicius Suartz, Mateus Silva Santos Costa, Caio Felipe Araujo Matalani, et al.
World Journal of Urology|July 27, 2012
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?Michael Rink, Shahrokh F Shariat, Evanguelos Xylinas, et al.
Pageof 33